CoChat

Assessing the Benefits of Drug Delivery by Nanocarriers: A Partico/Pharmacokinetic Framework

Siegel, Ronald A., Kirtane, Ameya R., Panyam, Jayanth · 2017 · IEEE Transactions on Biomedical Engineering

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: An in vivo kinetic framework is introduced to analyze and predict the quantitative advantage of using nanocarriers to deliver drugs, especially anticancer agents, compared to administering the same drugs in their free form. METHODS: This framework recognizes three levels of kinetics. First is the particokinetics associated with deposition of nanocarriers into tissues associated with drug effect and toxicity, their residence inside those tissues, and elimination of the nanocarriers from the body. Second is the release pattern in time of free drug from the nanocarriers. Third is the pharmacokinetics of free drug, as it relates to deposition and elimination processes in the target and toxicity associated tissues, and total body clearance. A figure of merit, the drug targeting index (DTI), is used to quantitate the benefit of nanocarrier-based drug delivery by considering the effects of preferential deposition of nanoparticles into target tissues and relative avoidance of tissues associated with drug toxicity, compared to drug that is administered in its free form. RESULTS: General methods are derived for calculating DTI when appropriate particokinetic, pharmacokinetic, and drug release rate information is available, and it is shown that relatively simple algebraic forms result when some common assumptions are made. CONCLUSION: This approach may find use in developing and selecting nanocarrier formulations, either for populations or for individuals.

Overview

Integrity signals

Registry

Crossref · 10.1109/tbme.2016.2632733

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Cited by

See all 15

Metadata

Authors
Siegel, R. A., Kirtane, A. R., & Panyam, J.
Affiliations
University of Minnesota (US)
Venue
IEEE Transactions on Biomedical Engineering
Published
2017-09
Volume
64
Issue
9
Pages
2176-2185
ISSN
  • 0018-9294 (ISSN-L)
  • 1558-2531
OpenAlex
W2558264310
Cited by
14
References
57
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1
FWCI
0.41
Type
journal article
Language
en
Open access
closed
Locations
  • IEEE Transactions on Biomedical Engineering (publishedVersion)
  • PubMed (publishedVersion)
Funders
Doctoral Dissertation Fellowship from the University of Minnesota
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
nanocarriers, drug delivery, pharmacokinetics, anticancer agents, drug release kinetics, drug toxicity, personalized drug delivery
MeSH terms
Animals, Antineoplastic Agents, Biological Availability, Computer Simulation, Diffusion, Drug Evaluation, Preclinical, Humans, Models, Biological, Models, Chemical, Neoplasms, Drug Design, Nanocapsules

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.